Gene · 6891
Papers2,915
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,915
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advancing tuberculosis management: the role of predictive, preventive, and personalized medicine. | Front Microbiol | 2023 | 37860132 | PubTator, text mining | PubMed |
| Tumor microenvironment-responsive DNA-based nanomedicine triggers innate sensing for enhanced immunotherapy. | J Nanobiotechnology | 2023 | 37858171 | PubTator, text mining | PubMed |
| Two bullets in the gun: combining immunotherapy with chemotherapy to defeat neuroblastoma by targeting adrenergic-mesenchymal plasticity. | Front Immunol | 2023 | 37849756 | PubTator, text mining | PubMed |
| SARS-CoV-2 mutations affect antigen processing by the proteasome to alter CD8+ T cell responses. | Heliyon | 2023 | 37842619 | PubTator, text mining | PubMed |
| Integration of bioinformatics and machine learning strategies identifies APM-related gene signatures to predict clinical outcomes and therapeutic responses for breast cancer patients. | Neoplasia | 2023 | 37839160 | PubTator, text mining | PubMed |
| Identification of IL-27 as a novel regulator of major histocompatibility complex class I and class II expression, antigen presentation, and processing in intestinal epithelial cells. | Front Immunol | 2023 | 37818353 | PubTator, text mining | PubMed |
| Disabled-2: a protein up-regulated by high molecular weight hyaluronan has both tumor promoting and tumor suppressor roles in ovarian cancer. | Cell Mol Life Sci | 2023 | 37815603 | PubTator, text mining | PubMed |
| The herpesvirus UL49.5 protein hijacks a cellular C-degron pathway to drive TAP transporter degradation. | bioRxiv | 2023 | 37808699 | PubTator, text mining | PubMed |
| The interplay between neoantigens and immune cells in sarcomas treated with checkpoint inhibition. | Front Immunol | 2023 | 37799721 | PubTator, text mining | PubMed |
| Obesity accelerates endothelial-to-mesenchymal transition in adipose tissues of mice and humans. | Front Cardiovasc Med | 2023 | 37795485 | PubTator, text mining | PubMed |
| Pre-pregnancy gene expression signatures are associated with subsequent improvement/worsening of rheumatoid arthritis during pregnancy. | Arthritis Res Ther | 2023 | 37794420 | PubTator, text mining | PubMed |
| Noncoding RNAs as an emerging resistance mechanism to immunotherapies in cancer: basic evidence and therapeutic implications. | Front Immunol | 2023 | 37767098 | PubTator, text mining | PubMed |
| Impact of Treatment with Ustekinumab on Severe Infections in a Patient with Uncontrolled Psoriasis and Late-Onset Combined Primary Immunodeficiency: Case Report. | Pathogens | 2023 | 37764964 | PubTator, text mining | PubMed |
| Rapid SERS Detection of Botulinum Neurotoxin Type A. | Nanomaterials (Basel) | 2023 | 37764560 | PubTator, text mining | PubMed |
| Comprehensive proteomics and meta-analysis of COVID-19 host response. | Nat Commun | 2023 | 37739942 | PubTator, text mining | PubMed |
| ABCC1 and glutathione metabolism limit the efficacy of BCL-2 inhibitors in acute myeloid leukemia. | Nat Commun | 2023 | 37726279 | PubTator, text mining | PubMed |
| Microfluidic design in single-cell sequencing and application to cancer precision medicine. | Cell Rep Methods | 2023 | 37725985 | PubTator, text mining | PubMed |
| Pan-cancer analysis of kinesin family members with potential implications in prognosis and immunological role in human cancer. | Front Oncol | 2023 | 37711200 | PubTator, text mining | PubMed |
| Integrated Immunopeptidomics and Proteomics Study of SARS-CoV-2-Infected Calu-3 Cells Reveals Dynamic Changes in Allele-specific HLA Abundance and Antigen Presentation. | Mol Cell Proteomics | 2023 | 37709257 | PubTator, text mining | PubMed |
| Publicly available ex vivo transcriptomics datasets to explore CNS physiology and neurodegeneration: state of the art and perspectives. | Front Neurosci | 2023 | 37680966 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6891/papers?page=8